DK1586634T3 - Fremgangsmåde til fremstilling af infektiös reovirus - Google Patents
Fremgangsmåde til fremstilling af infektiös reovirusInfo
- Publication number
- DK1586634T3 DK1586634T3 DK05009952T DK05009952T DK1586634T3 DK 1586634 T3 DK1586634 T3 DK 1586634T3 DK 05009952 T DK05009952 T DK 05009952T DK 05009952 T DK05009952 T DK 05009952T DK 1586634 T3 DK1586634 T3 DK 1586634T3
- Authority
- DK
- Denmark
- Prior art keywords
- producing infectious
- infectious reovirus
- reovirus
- producing
- infectious
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22402600P | 2000-08-10 | 2000-08-10 | |
| PCT/CA2001/001054 WO2002012435A1 (en) | 2000-08-10 | 2001-07-20 | Method of producing infectious reovirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1586634T3 true DK1586634T3 (da) | 2008-08-18 |
Family
ID=22838987
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01953084T DK1309672T3 (da) | 2000-08-10 | 2001-07-20 | Fremgangsmåde til fremstilling af infektiös reovirus |
| DK05009952T DK1586634T3 (da) | 2000-08-10 | 2001-07-20 | Fremgangsmåde til fremstilling af infektiös reovirus |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01953084T DK1309672T3 (da) | 2000-08-10 | 2001-07-20 | Fremgangsmåde til fremstilling af infektiös reovirus |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US6528305B2 (da) |
| EP (2) | EP1586634B1 (da) |
| JP (2) | JP4009532B2 (da) |
| AR (1) | AR033993A1 (da) |
| AT (2) | ATE298788T1 (da) |
| AU (2) | AU7562801A (da) |
| BR (1) | BR0113122A (da) |
| CA (1) | CA2415749C (da) |
| DE (2) | DE60133947D1 (da) |
| DK (2) | DK1309672T3 (da) |
| ES (2) | ES2305940T3 (da) |
| HK (1) | HK1082765A1 (da) |
| IL (2) | IL153847A0 (da) |
| MX (1) | MXPA03000846A (da) |
| NZ (1) | NZ523510A (da) |
| PT (2) | PT1586634E (da) |
| TW (1) | TWI289158B (da) |
| WO (1) | WO2002012435A1 (da) |
| ZA (1) | ZA200300410B (da) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6545492B1 (en) * | 1999-09-20 | 2003-04-08 | Europaisches Laboratorium Fur Molekularbiologie (Embl) | Multiple local probe measuring device and method |
| TWI289158B (en) * | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
| EP2253701B1 (en) | 2001-03-16 | 2014-08-13 | Oncolytics Biotech Inc. | Method of extracting virus from cell culture |
| US20040115170A1 (en) * | 2001-11-30 | 2004-06-17 | Brown Earl Garnet | Oncolytic virus |
| CA2374388C (en) * | 2002-02-28 | 2005-07-12 | Matthew C. Coffey | The use of ribozymes in the detection of adventitious agents |
| US20040005546A1 (en) | 2002-02-28 | 2004-01-08 | Oncolytics Biotech Inc. | Use of ribozymes in the detection of adventitious agents |
| JP3943048B2 (ja) * | 2002-04-29 | 2007-07-11 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 組織の細胞ｄｎａからの組込みウイルスの直接レスキュー及び増幅の方法 |
| ES2323454T5 (es) * | 2002-04-30 | 2012-11-14 | Oncolytics Biotech Inc. | Procedimiento mejorado de purificación de virus |
| CA2484398C (en) * | 2002-05-09 | 2014-01-21 | Oncolytics Biotech Inc. | Method for reducing pain using oncolytic viruses |
| EP1944035A1 (en) | 2002-05-09 | 2008-07-16 | Oncolytics Biotech Inc. | Method for reducing pain using oncolytic viruses |
| NZ536062A (en) * | 2002-05-10 | 2008-03-28 | Oncolytics Biotech Inc | Sensitization of neoplastic cells to radiation therapy with oncolytic viruses |
| US7901921B2 (en) | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
| US7455063B2 (en) * | 2005-06-17 | 2008-11-25 | Nellcor Puritan Bennett Llc | Adjustable gas delivery mask having a flexible gasket |
| US10668119B2 (en) | 2005-08-01 | 2020-06-02 | Virocure, Inc. | Attenuated reovirus |
| CA2617600A1 (en) | 2005-08-01 | 2007-09-07 | University Technologies International, Inc. | Attenuated reovirus |
| ES2551306T3 (es) * | 2006-02-13 | 2015-11-17 | Oncolytics Biotech Inc. | Uso de inmunosupresión local de baja dosis para potenciar una terapia viral oncolítica |
| US8293498B2 (en) | 2006-12-20 | 2012-10-23 | Vanderbilt University | System for generation of viable reovirus from cloned cDNA |
| WO2008127486A2 (en) * | 2006-12-29 | 2008-10-23 | Bacilligen, Inc. | Replication-proficient dsrna capsids and uses thereof |
| KR101647843B1 (ko) | 2007-03-12 | 2016-08-11 | 온콜리틱스 바이오테크 인코포레이티드 | 변형된 서열을 갖는 레오바이러스 |
| US10369171B2 (en) | 2007-03-13 | 2019-08-06 | Virocure, Inc. | Attenuated reoviruses for selection of cell populations |
| TW200909581A (en) * | 2007-05-21 | 2009-03-01 | Oncolytics Biotech Inc | Mutant reoviruses and methods of making and using |
| WO2009052617A1 (en) * | 2007-10-22 | 2009-04-30 | Oncolytics Biotech Inc. | Treatment regime for proliferative disorders |
| WO2009143610A1 (en) * | 2008-05-27 | 2009-12-03 | Oncolytics Biotech Inc. | Modulating interstitial pressure and oncolytic viral delivery and distribution |
| MX2010012857A (es) * | 2008-05-27 | 2010-12-20 | Oncolytics Biotech Inc | Supresion de produccion de citoquina proinflamatoria durante la terapia de reovirus oncolitico. |
| US9249195B2 (en) | 2010-04-07 | 2016-02-02 | Vanderbilt University | Reovirus vaccines and methods of use therefor |
| CN102985536B (zh) | 2010-04-14 | 2017-12-05 | Emd密理博公司 | 生产高效价、高纯度的病毒母液的方法及使用其的方法 |
| WO2012075379A2 (en) | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Liquid viral formulations |
| CA2819236A1 (en) | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
| ES2796950T3 (es) | 2013-11-15 | 2020-11-30 | Oncolytics Biotech Inc | Virus oncolíticos y regímenes reforzados para tratamiento de cáncer |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4070453A (en) * | 1976-06-25 | 1978-01-24 | Syntex (U.S.A.) Inc. | Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines |
| US4559229A (en) * | 1982-07-20 | 1985-12-17 | Research Foundation | Avian proventriculitis vaccine |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| JPS6344532A (ja) | 1986-08-11 | 1988-02-25 | Biseibutsu Kagaku Kenkyusho:Kk | 豚のレオウイルス感染症ワクチン |
| US5658779A (en) | 1992-03-20 | 1997-08-19 | Ligochem, Inc. | Method of adsorbing viruses from fluid compositions |
| JPH08214876A (ja) | 1995-02-15 | 1996-08-27 | Chemo Sero Therapeut Res Inst | ウイルスの調製法 |
| EP0968284B1 (en) | 1996-11-20 | 2006-12-13 | Introgen Therapeutics, Inc. | An improved method for the production and purification of adenoviral vectors |
| CA2283894A1 (en) | 1997-06-24 | 1998-12-30 | Basf Aktiengesellschaft | Method for producing 4,4' dihalogendiphenylsulfone |
| US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
| US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| AR028039A1 (es) | 2000-05-03 | 2003-04-23 | Oncolytics Biotech Inc | Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas |
| TWI289158B (en) * | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
-
2001
- 2001-07-19 TW TW90117712A patent/TWI289158B/zh not_active IP Right Cessation
- 2001-07-20 ES ES05009952T patent/ES2305940T3/es not_active Expired - Lifetime
- 2001-07-20 PT PT05009952T patent/PT1586634E/pt unknown
- 2001-07-20 EP EP20050009952 patent/EP1586634B1/en not_active Expired - Lifetime
- 2001-07-20 AU AU7562801A patent/AU7562801A/xx active Pending
- 2001-07-20 JP JP2002517726A patent/JP4009532B2/ja not_active Expired - Lifetime
- 2001-07-20 WO PCT/CA2001/001054 patent/WO2002012435A1/en active IP Right Grant
- 2001-07-20 AU AU2001275628A patent/AU2001275628B2/en not_active Expired
- 2001-07-20 ZA ZA200300410A patent/ZA200300410B/xx unknown
- 2001-07-20 IL IL15384701A patent/IL153847A0/xx active IP Right Grant
- 2001-07-20 CA CA 2415749 patent/CA2415749C/en not_active Expired - Lifetime
- 2001-07-20 DE DE60133947T patent/DE60133947D1/de not_active Expired - Lifetime
- 2001-07-20 PT PT01953084T patent/PT1309672E/pt unknown
- 2001-07-20 DK DK01953084T patent/DK1309672T3/da active
- 2001-07-20 EP EP01953084A patent/EP1309672B1/en not_active Expired - Lifetime
- 2001-07-20 NZ NZ523510A patent/NZ523510A/en unknown
- 2001-07-20 AT AT01953084T patent/ATE298788T1/de not_active IP Right Cessation
- 2001-07-20 ES ES01953084T patent/ES2241844T3/es not_active Expired - Lifetime
- 2001-07-20 MX MXPA03000846A patent/MXPA03000846A/es active IP Right Grant
- 2001-07-20 DK DK05009952T patent/DK1586634T3/da active
- 2001-07-20 DE DE2001611747 patent/DE60111747T2/de not_active Expired - Lifetime
- 2001-07-20 AT AT05009952T patent/ATE394475T1/de not_active IP Right Cessation
- 2001-07-20 BR BR0113122A patent/BR0113122A/pt not_active IP Right Cessation
- 2001-08-02 US US09/920,012 patent/US6528305B2/en not_active Expired - Lifetime
- 2001-08-03 AR ARP010103738 patent/AR033993A1/es active IP Right Grant
-
2003
- 2003-01-08 US US10/337,911 patent/US6703232B2/en not_active Expired - Lifetime
- 2003-01-08 IL IL153847A patent/IL153847A/en unknown
- 2003-12-11 US US10/734,552 patent/US7049127B2/en not_active Expired - Lifetime
-
2006
- 2006-03-27 US US11/390,885 patent/US7429485B2/en not_active Expired - Lifetime
- 2006-04-03 HK HK06104055A patent/HK1082765A1/xx not_active IP Right Cessation
- 2006-08-30 JP JP2006234596A patent/JP2006314336A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1586634T3 (da) | Fremgangsmåde til fremstilling af infektiös reovirus | |
| DK1187231T3 (da) | Metode til fremstilling af oxid-superleder | |
| DK1978747T3 (da) | Fremgangsmåde til fjernelse af kodningsforvrængning | |
| DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
| DE60139615D1 (de) | Verbundmembran und herstellungsverfahren | |
| DK1169314T3 (da) | Krystallinsk base af citalopram | |
| CY2007029I1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| DK1293507T3 (da) | Fremgangsmåde til fremstilling af krystaller | |
| DK1432319T3 (da) | Fremgangsmåde til fremstilling af hundefoder | |
| DK1309581T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
| DK2135957T3 (da) | Fremgangsmåde til fremstilling af glucaner | |
| DK1353923T3 (da) | Forbedret fremgangsmåde til syntese af carbapenem | |
| DK1373268T3 (da) | Fremgangsmåde til fremstilling af anagrelid | |
| DE60130046D1 (de) | Knotenauswahlverfahren | |
| DK1326836T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin | |
| DK1296970T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
| DK1292586T3 (da) | Fremgangsmåde til fremstilling af pyrazolopyrimidinoner | |
| DK1286940T3 (da) | Fremgangsmåde til fluormethylering af alkoholer | |
| NO20032563L (no) | Filtreringsfremgangsmåte | |
| DK1286941T3 (da) | Syntetisk fremgangsmåde til fluormethylering af halogenerede alkoholer | |
| DE10294532D2 (de) | Künstlicher Lymphknoten | |
| ES1048083Y (es) | Bielas avanzadas de empuje tangencial | |
| DK1229109T3 (da) | Fremgangsmåde til fremstilling af glucose-1-phosphat | |
| NO20023714D0 (no) | Ny koblingsprosess | |
| DK1296983T3 (da) | Ny fremgangsmåde til fremstilling af pyrazolopyrimidinoner |